Towards Healthcare
Cell and Gene Therapy Infrastructure Market Growth Forecast 2025 to 2034

Cell and Gene Therapy Infrastructure Market Ignites Global Expansion

The cell and gene therapy infrastructure market is growing due to advances in gene editing technology and the increasing prevalence of genetic and chronic diseases. North America is dominant in the market due to the robust public and private spending.

Content

  • Last Updated: 13 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Kesiya Chacko is an accomplished market research professional with over 4+ years of experience in the healthcare industry, known for delivering actionable insights and strategic analysis that empower healthcare organizations to navigate complex, rapidly evolving markets.

Kesiya began her research career with Precedence Research, where she built a strong foundation in pharmaceutical and healthcare market analysis. Today, she plays an integral role at Towards Healthcare, contributing to in-depth, client-centric research initiatives. She also brings her expertise to Statifacts, supporting broader research functions with a focus on cross-sector healthcare trends and data interpretation.

Her commitment to high-quality analysis, combined with a strong grasp of regulatory and market dynamics, makes her a trusted contributor to healthcare firms seeking future-ready, data-backed decisions. Kesiya’s work spans the analysis of industry trends, competitive benchmarking, and evaluation of regulatory and innovation-driven shifts.

Talk to us
FAQ's

The cell and gene therapy infrastructure market is expected to reach new heights by 2034, driven by technological breakthroughs and changing consumer preferences.

North America is currently leading the cell and gene therapy infrastructure market due to extensive research and development (R&D) investments.

Some key players include Ori Biotech, Miltenyi Biotec, Akron Biotech, BioSpherix, Cellinoand QuickSTAT.

Cell and gene therapy are cutting-edge medical approaches that treat diseases by altering or replacing the genes within a patient cells or by introducing healthy cells to the body.

Ministry of Health and Family Welfare, FDA, WHO, PIB, CDC.
Any Questions